| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |